Dr. Weglein is a Managing Principal in Analysis Group’s Boston office. He specializes in applying economics, statistics, and valuation to the analysis of liability issues and damages in antitrust, finance and securities, and general business litigation matters. Much of his recent antitrust work has been in health insurance and hospital markets. He has also assisted with antitrust litigation in a number of financial benchmark cases, including LIBOR and foreign exchange matters. In addition, Dr. Weglein has analyzed the economics of prepackaged software and managed projects to assess potential damages involving alleged anticompetitive conduct by Microsoft. He has also worked on behalf of Intel in antitrust litigation matters brought by AMD and the State of New York. In securities and finance litigation matters, Dr. Weglein has worked on behalf of several large financial institutions. These projects have included valuing long-defaulted sovereign debt, assessing damages arising from collateral calls on a total return swap, analyzing the reasonableness of the corporate governance regime of a publicly traded REIT, measuring the economic harm caused by management in a dispute over corporate control, and measuring the impact of short sales on securities prices. Dr. Weglein’s experience spans numerous industries, including health and life insurance, investment and commercial banking, securities brokerage and clearing, asset management, semiconductors, computer hardware and software, minerals, oil and gas, shipping, automotive, food packaging, steel, real estate, medical devices, agribusiness, and biotechnology. He has coauthored a number of publications, including three white papers addressing the incentives facing dealers and manufacturers in the auto and heavy-duty vehicle industry.